• Markets
    • icon
  • Companies
ACR · ASX

Acrux Limited (ASX:ACR)

AU$0.066

 -0.003 (-4.348%)
ASX:Live
26/07/2024 04:10:15 PM
HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

ACR Overview

ACR Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About ACR

Website

Acrux Limited

Telephone

61.3.8379.0100

Address

103-113 Stanley Street West Melbourne, Victoria (VIC) 3003

Description

Acrux Ltd. operates as a pooled development fund that invests in pharmaceutical businesses. The firm develops and commercializes pharmaceutical products using unique technology to administer drugs through the skin. Its products brands include AXIRON, ELLAVIE & EVAMIST and RECUVYRA. The company was founded by Ross Dobinson and Barrie Charles Finnin in 1998 and is headquartered in West Melbourne, Australia.

ACR Price Chart

Key Stats

Market Cap

AU$20.06M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.04 - 0.1

Trade Value (12mth)

AU$5,542.00

1 week

2.99%

1 month

-2.82%

YTD

40.82%

1 year

40.82%

All time high

4.52

Key Fundamentals

EPS 3 yr Growth

-95.200%

EBITDA Margin

-33.20%

Operating Cashflow

$1m

Free Cash Flow Return

6.40%

ROIC

-7.00%

Interest Coverage

N/A

Quick Ratio

4.10

Other Data

Shares on Issue (Fully Dilluted)

289m

HALO Sector

Healthcare

Next Company Report Date

23-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

ACR Announcements

Latest Announcements

Date Announcements

15 July 24

Acrux presentation to Bioshares, 18th Biotech Summit

×

Acrux presentation to Bioshares, 18th Biotech Summit

28 June 24

RDTI funding facility secured

×

RDTI funding facility secured

13 June 24

Acrux presentation at Hidden Gems in Lifesciences Forum

×

Acrux presentation at Hidden Gems in Lifesciences Forum

30 April 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

30 April 24

Quarterly Activities and Appendix 4C, reissued

×

Quarterly Activities and Appendix 4C, reissued

03 April 24

Launch of Dapsone 5%, Gel in the United States

×

Launch of Dapsone 5%, Gel in the United States

05 March 24

Application for quotation of securities - ACR

×

Application for quotation of securities - ACR

05 March 24

Appendix 3Y Brumley

×

Appendix 3Y Brumley

05 March 24

Appendix 3Y Dobinson

×

Appendix 3Y Dobinson

27 February 24

Appendix 4D and Half Year Accounts

×

Appendix 4D and Half Year Accounts

27 February 24

Investor Presentation Half Year Accounts

×

Investor Presentation Half Year Accounts

23 February 24

Investor Webinar Details - Financial Results 1H FY24

×

Investor Webinar Details - Financial Results 1H FY24

14 February 24

Notification regarding unquoted securities - ACR

×

Notification regarding unquoted securities - ACR

14 February 24

Application for quotation of securities - ACR

×

Application for quotation of securities - ACR

31 January 24

Appendix 4C and Activities Statement

×

Appendix 4C and Activities Statement

20 December 23

Application for quotation of securities - ACR

×

Application for quotation of securities - ACR

20 December 23

Appendix 3Y Brooke

×

Appendix 3Y Brooke

20 December 23

Appendix 3Y Oldham

×

Appendix 3Y Oldham

05 December 23

Notification regarding unquoted securities - ACR

×

Notification regarding unquoted securities - ACR

05 December 23

Appendix 3Y Brooke

×

Appendix 3Y Brooke

05 December 23

Appendix 3Y Brumley

×

Appendix 3Y Brumley

05 December 23

Appendix 3Y Dobinson

×

Appendix 3Y Dobinson

05 December 23

Appendix 3Y Oldham

×

Appendix 3Y Oldham

29 November 23

Address of Chair and CEO to AGM

×

Address of Chair and CEO to AGM

29 November 23

Results of AGM

×

Results of AGM

ACR Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.06 -0.03 -0.00 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.06 -0.03 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock -2.0 39.8 92.2 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.04 -0.03 0.00 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.05 -0.03 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 19.2 25.3 106.1 Lock Lock Lock
     Yield % Lock Lock Lock Lock -40.3 -62.9 4.9 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.07 0.03 0.03 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.06 0.03 0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock -12.7 -51.9 -1.2 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 220 284 286 Lock Lock Lock
Basic m Lock Lock Lock Lock 220 284 286 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 1 2 8 Lock Lock Lock
     Growth % Lock Lock Lock Lock 6.7 28.6 390.3 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 17 14 5 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock N/A N/A 2 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A 23.1 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock N/A N/A 77 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -16 -12 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock -37.1 21.0 77.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1,165.7 -715.9 -33.2 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -16 -13 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock -34.6 20.2 73.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1,215.5 -754.3 -40.2 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -16 -13 -4 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -3 -3 -3 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -13 -10 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -33.3 22.1 92.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -944.6 -572.1 -9.1 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -11 -9 1 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 18 0 0 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -12 -9 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -31.0 19.4 106.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -8.6 -5.4 0.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 44 44 44 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 15 6 6 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 24 15 14 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 2 2 2 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -13 -4 -4 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 6 6 6 Lock Lock Lock
Equity $m Lock Lock Lock Lock 18 9 9 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 21 11 11 Lock Lock Lock
     Growth % Lock Lock Lock Lock 36.0 -46.7 -0.8 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -52.2 -64.4 -5.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -68.4 -108.2 -8.8 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -90.4 -81.4 -30.5 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -70.9 -62.5 -7.0 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -64.1 -56.1 6.4 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.8 0.3 1.4 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -70.6 -41.3 -44.6 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 6.7 3.0 4.1 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 6.7 3.0 4.1 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 82.1 58.2 63.0 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -412.7 -265.8 29.4 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.5 0.5 2.4 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.1 0.3 1.1 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 23.3 45.9 5.8 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.1 0.1 0.6 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.1 0.1 0.6 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -1,185.7 -753.2 -42.6 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -65.5 -84.8 -25.1 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -52.2 -64.4 -5.3 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.3 1.7 1.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -68.4 -108.2 -8.8 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -68.4 -108.2 -8.8 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 780.5 735.1 153.1 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 780.5 735.1 153.1 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock N/A N/A 35.9 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 780.5 735.1 117.1 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

ACR Shortsell

Frequently Asked Questions

The current share price of Acrux Limited (ACR:ASX) is AU$0.066.
The 52-week high share price for Acrux Limited (ACR:ASX) is AU$0.10.
The 52-week low share price for Acrux Limited (ACR:ASX)? is AU$0.04.
Acrux Limited (ACR:ASX) does not pay a dividend.
The last dividend payment of Acrux Limited (ACR:ASX) is AU$0.06.
Acrux Limited (ACR:ASX) has a franking level of 0.0%.
Acrux Limited (ACR:ASX) is classified in the Healthcare.
The current P/E ratio for Acrux Limited (ACR:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.